• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Dime Bancorp

Dime Bancorp

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Research and Markets: Regeneron and Bayer AG's Eylea (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

    Research and Markets: Regeneron and Bayer AG's Eylea (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

  2. Research and Markets: Avastin (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

    Research and Markets: Avastin (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

  3. Preparing for a Brent Benchmark With No Brent Oil

    Preparing for a Brent Benchmark With No Brent Oil

  4. Research and Markets: Genentech/Roche's Lucentis (ranibizumab) Macular Edema and Macular Degeneration Drug Forecast and Market Analysis to 2023

    Research and Markets: Genentech/Roche's Lucentis (ranibizumab) Macular Edema and Macular Degeneration Drug Forecast and Market Analysis to 2023

  5. Research and Markets: QLT PhotoTherapeutics and Novartis Pharma AG's Visudyne (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

    Research and Markets: QLT PhotoTherapeutics and Novartis Pharma AG's Visudyne (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

  6. Univita Health Secures $40M Credit Facility to Fund Future Growth

    Univita Health Secures $40M Credit Facility to Fund Future Growth

  7. CME Group Appoints Christopher Fix as Head of Asia Pacific

    CME Group Appoints Christopher Fix as Head of Asia Pacific

  8. Complexities of Eye Care Drive Strong Moats

    We see attractive growth opportunities for the ophthalmology market.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.